Fuji Pharma Co., Ltd.

63
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3816200004
JPY
1,729.00
3 (0.17%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
No of Months
12
12
12
12
12
12
Operating Income
46,138.00
40,889.00
35,426.00
33,990.00
33,793.00
36,279.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
46,138.00
40,889.00
35,426.00
33,990.00
33,793.00
36,279.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
196.00
121.00
77.00
53.00
37.00
41.00
General and Administration Expenses
9,231.00
8,331.00
7,355.00
8,340.00
8,048.00
8,957.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
42,257.00
37,030.00
31,648.00
30,641.00
30,653.00
32,105.00
Operating Profit (PBDIT) excl Other Income
3,881.00
3,859.00
3,778.00
3,349.00
3,140.00
4,174.00
Other Income
3,246.00
417.00
309.00
86.00
-184.00
-94.00
Operating Profit (PBDIT)
10,807.00
7,299.00
6,832.00
5,541.00
5,013.00
6,209.00
Interest
196.00
121.00
77.00
53.00
37.00
41.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
3,680.00
3,023.00
2,745.00
2,106.00
2,057.00
2,129.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
8,276.00
4,399.00
3,723.00
3,371.00
2,918.00
3,961.00
Provision for Tax
2,128.00
963.00
1,026.00
938.00
832.00
998.00
Profit After Tax
6,147.00
3,435.00
2,697.00
2,432.00
2,085.00
2,962.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
252.81
141.35
110.98
90.52
66.92
97.02
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Sep 2024 is 12.84% vs 15.42% in Sep 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Sep 2024 is 0.57% vs 2.14% in Sep 2023

stock-summary

Interest

YoY Growth in year ended Sep 2024 is 61.98% vs 57.14% in Sep 2023

stock-summary

Profit After Tax

YoY Growth in year ended Sep 2024 is 78.95% vs 27.36% in Sep 2023

Compare Profit and Loss Results of Fuji Pharma Co., Ltd.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
No of Months
12
12
Operating Income
46,138.00
46,895.00
-757.00
-1.61%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
46,138.00
46,895.00
-757.00
-1.61%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
196.00
41.00
155.00
378.05%
General and Administration Expenses
9,231.00
3,431.00
5,800.00
169.05%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
42,257.00
43,001.00
-744.00
-1.73%
Operating Profit (PBDIT) excl Other Income
3,881.00
3,894.00
-13.00
-0.33%
Other Income
3,246.00
322.00
2,924.00
908.07%
Operating Profit (PBDIT)
10,807.00
7,875.00
2,932.00
37.23%
Interest
196.00
41.00
155.00
378.05%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
3,680.00
3,659.00
21.00
0.57%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
8,276.00
4,218.00
4,058.00
96.21%
Provision for Tax
2,128.00
1,040.00
1,088.00
104.62%
Profit After Tax
6,147.00
3,294.00
2,853.00
86.61%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
252.812
104.9965
147.82
140.78%
Profit And Loss - Net Sales
Net Sales 46,138.00 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is 12.84% vs 15.42% in Sep 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3,881.00 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is 0.57% vs 2.14% in Sep 2023

Profit And Loss - Interest
Interest 196.00 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is 61.98% vs 57.14% in Sep 2023

Profit And Loss - Profit After Tax
Profit After Tax 6,147.00 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is 78.95% vs 27.36% in Sep 2023